Drug intelligence / Profile preview

whey protein (Ingram Biosciences)

Development stage: Unknown
Lead developer: Ingram Biosciences
Modality: Recombinant Proteins and Enzymes
Administration: Oral

Overview

GRAMOZ HP is a nutritional supplement developed by Ingram Biosciences, primarily composed of whey protein. As a high-quality protein source, it provides a complete profile of essential amino acids necessary for muscle protein synthesis, tissue repair, and the maintenance of lean body mass. It is typically utilized to support patients with increased protein requirements, such as those recovering from illness, surgery, or managing chronic conditions associated with muscle wasting and nutritional deficiencies.

Brand names: GRAMOZ HP
Other names: whey protein

Beyond the preview

Go deeper on whey protein (Ingram Biosciences).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on whey protein (Ingram Biosciences).

Explore the full profile